Arch Medical Services, Inc.

St Louis, Missouri 63142

0 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Hodgkin's Lymphoma, Lymphoma, Non-Hodgkin, Metastatic Breast Cancer

Studies at this site

• PhII ICb With/Without Erbitux in MBC Pts — Running, not enrolling
• TAC Versus TC for Adjuvant Breast Cancer — Completed
• Adj TC + Herceptin Early Stage Breast Cancer — Completed
• Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer — Completed
• Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) — Completed
• Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma — Completed
• Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy — Stopped early